One of the first brain measurement...
A modern neurological study aims to relate several biomarkers from different sources in order to explain the illness evolution improve prognostic accuracy and optimize the treatment.
A modern research group can have at disposal:
Neuroimaging offers a fecund source of biomarkers
1. Registration (rigid, affine, nonlinear)
2. Correction (Bias Field, Lesion Filling,
Motion Correction, PVC)
3. Segmentation (Manual, Template-based)
4. Measurement (mean, std over VOIs)
Motion Correction
Partial Volume Correction
Cortical Thickness Estimation
Lesion filling algorithms in MS try to inpaint T1 hypo-intense WM lesion (about 30% of FLAIR-appearing lesions) as Normal-Appearing White Matter (NAWM).
This procedure has shown to improve:
This procedure has NOT been studied before over Cortical Lesions: only ~15% appear as hypo-intense in T1.
29 patients, 14 CIS/eRRMS and 15 RRMS underwent a PET/MRI with:
The aim is to study the relationship between:
Results are hard to put together!
No correlation was demonstrated between CTh and WM and GM lesion load
No correlation was found between global and regional aMRglu and CTh.
aMRglu correlated with lesion load
Inverse correlation was found between:
86 cases (53 rated negatively and 33 positively by expert amyloid readers) of 18F-Fluorbetaben PET/MRI.
R2
SI
WMR
ROC (Receiver Operator Charateristic) curves
Normalization
z-score
MS Centre Padova
Nuclear Medicine Padova
Neurology Padova
Neuroradiology Unit Padova
Nuclear Medicine Leipzig DE
all patients of course ...
TG Feeman, The mathematics of medical imaging: A beginners guide, Springer, 2010